医疗服务行业周报：卫生行业AI应用指引发布，医药领域人工智能应用广泛

Investment Rating - The industry rating is maintained at "Overweight" [9] Core Insights - The pharmaceutical and biological sector experienced a decline of 3.92%, ranking 18th among the 31 primary industries in the Shenwan classification. The medical service sector specifically saw a drop of 5.51%, indicating a significant downturn in performance [6][29] - The current price-to-earnings (PE) ratio for the medical service sector is 35.35x, with a historical maximum of 38.94x and a minimum of 20.88x over the past year. The price-to-book (PB) ratio stands at 2.89x, with a maximum of 4.21x and a minimum of 2.06x during the same period [7][41] - The report emphasizes the growing application of artificial intelligence (AI) in various medical fields, including clinical decision-making, surgical robots, and drug design, suggesting that these areas may present significant investment opportunities [13][80] Summary by Sections Industry Performance - The medical service sector reported a significant decline of 5.51%, with the Shenwan medical service index closing at 5264.16 points. Other sub-sectors also faced declines, with traditional Chinese medicine down 3.99% and chemical pharmaceuticals down 4.08% [6][29] - Notable performers in the medical service sector included Hongbo Pharmaceutical (+9.0%) and Digital Human (+7.6%), while companies like NuoSiGe (-11.2%) and BoTeng Co. (-9.9%) faced substantial losses [39] Valuation Metrics - The current PE ratio for the medical service sector is 35.35x, reflecting a decrease of 2.11x from the previous week. The PB ratio has also decreased by 0.17x, indicating a downward trend in valuations [7][41] - The medical service sector's valuation is at the 20.71% historical percentile over the past decade, suggesting it is relatively undervalued compared to historical averages [41] Industry Dynamics and Announcements - The National Health Commission has issued guidelines to support the compliant marketing and academic exchange of pharmaceutical companies, aiming to foster a transparent and fair industry environment [72] - A joint directive from health authorities has been released to promote the application of AI in healthcare, focusing on improving diagnostic accuracy and patient experience through advanced technologies [72][76]